Céline Breda
Technik-/Wissenschafts-/F&E-Leiter bei PHAXIAM THERAPEUTICS S.A.
Profil
Céline Breda is currently the Chief Technical Officer at PHAXIAM Therapeutics SA since 2023.
Prior to this, she worked at Vivalis SA from 2005 to 2013 as Joint Managing Director & Head-Quality Control.
She also worked as Director-Industrial Operations at Pherecydes Pharma SA.
Aktive Positionen von Céline Breda
| Unternehmen | Position | Beginn |
|---|---|---|
| PHAXIAM THERAPEUTICS S.A. | Technik-/Wissenschafts-/F&E-Leiter | 23.06.2023 |
Ehemalige bekannte Positionen von Céline Breda
| Unternehmen | Position | Ende |
|---|---|---|
Vivalis SA
 Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France. | Präsident | 20.07.2010 |
| PHERECYDES PHARMA | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHAXIAM THERAPEUTICS S.A. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Vivalis SA
Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France. | Health Technology |
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
